A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets
Status:
Completed
Trial end date:
2018-11-06
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to investigate the relative bioavailability of Movalis
capsules 15 mg (Test, T) versus Movalis tablets 15 mg (Reference, R).
The secondary objective of the study is to establish bioequivalence of Movalis capsules 15 mg
(Test, T) versus Movalis tablets 15 mg (Reference, R).